Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Regulatory Alchemy: The Transformative Power of the Opioid REMS

This article was originally published in RPM Report

Executive Summary

The three-year long process towards a class-wide Risk Evaluation & Mitigation Strategy has been anything but straightforward. Still, the final twist may be the most surprising: FDA is now espousing the most industry-friendly approach on the table. The details of the opioid REMS will take months to work out and years to judge, but understanding the choices made in crafting this policy are a critical starting point.

Related Content

Zogenix Zohydro Launch Will Test FDA’s Balanced Approach On Opioid Pain Reviews
DEA Delays in Scheduling Are Offsetting FDA’s Improved Decision Making
FDAAA Impact Analysis (Year 4): The REMS Retreat Continues, But For How Long?
Controlling Opioids: REMS Meets Congressional Resistance
King of Pain: Pfizer's Move into Abuse Resistant Opioids and the Virtues of Massive Scale
Opioid REMS: Committee Rejects FDA Proposal, But Sponsors Should Embrace It
FDA Turns Back To CME as Opioid Control Tool
The Opioid REMS: Health Care Reform, One Class at a Time
Re-Defining Innovation in Pain Therapy: A Conversation with King's Management Team
Pyramid Schemes and Pipeline Dreams: Adapting to a Tiered Regulatory System for New Drugs


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts